Endoplasmic reticulum-resident selenoproteins and their roles in glucose and lipid metabolic disorders
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024
DOI: 10.1016/j.bbadis.2024.167246 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Zhan Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: Selenoproteins, Endoplasmic Reticulum, Lipid Metabolism. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 174 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Glucose and lipid metabolic disorders (GLMDs), such as diabetes, dyslipidemia, metabolic syndrome, nonalcoholic fatty liver disease, and obesity, are significant public health issues that negatively impact human health. The endoplasmic reticulum (ER) plays a crucial role at the cellular level for lipid and sterol biosynthesis, intracellular calcium storage, and protein post-translational modifications. Imbalance and dysfunction of the ER can affect glucose and lipid metabolism. As an essential trace element, selenium contributes to various human physiological functions mainly through 25 types of selenoproteins (SELENOs). At least 10 SELENOs, with experimental and/or computational evidence, are predominantly found on the ER membrane or within its lumen. Two iodothyronine deiodinases (DIOs), DIO1 and DIO2, regulate the thyroid hormone deiodination in the thyroid and some external thyroid tissues, influencing glucose and lipid metabolism. Most of the other eight members maintain redox homeostasis in the ER. Especially, SELENOF, SELENOM, and SELENOS are involved in unfolded protein responses; SELENOI catalyzes phosphatidylethanolamine synthesis; SELENOK, SELENON, and SELENOT participate in calcium homeostasis regulation; and the biological significance of thioredoxin reductase 3 in the ER remains unexplored despite its established function in the thioredoxin system. This review examines recent research advances regarding ER SELENOs in GLMDs and aims to provide insights on ER-related pathology through SELENOs regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China; Guangdong Provincial Engineering Laboratory for Nutrition Translation, Guangzhou 510080, China; Guangdong Provincial…
Förderung
- Shenzhen Science and Technology Innovation Commission
- National Natural Science Foundation of China
Zitieren
APA
Shi, Z., Han, Z., Chen, J., & Zhou, J. C. (2024). Endoplasmic reticulum-resident selenoproteins and their roles in glucose and lipid metabolic disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167246
Vancouver
Shi Z, Han Z, Chen J, Zhou JC. Endoplasmic reticulum-resident selenoproteins and their roles in glucose and lipid metabolic disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167246
BibTeX
@article{Shi2024,
author = {Shi, Zhan and Han, Ziyu and Chen, Jingyi and Zhou, Ji-Chang},
title = {Endoplasmic reticulum-resident selenoproteins and their roles in glucose and lipid metabolic disorders},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2024},
doi = {10.1016/j.bbadis.2024.167246}
}
EUVIMED